BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 19573500)

  • 1. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
    Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
    Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
    Cookson J; Hodgson R; Wildgust HJ
    J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-induced hyperprolactinaemia.
    Inder WJ; Castle D
    Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
    Hummer M; Huber J
    Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin awareness: an essential consideration for physical health in schizophrenia.
    Montejo AL
    Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
    Holt RI; Peveler RC
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):141-7. PubMed ID: 20455888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
    Smith S; Wheeler MJ; Murray R; O'Keane V
    J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal side effects in women: typical versus atypical antipsychotic treatment.
    Dickson RA; Seeman MV; Corenblum B
    J Clin Psychiatry; 2000; 61 Suppl 3():10-5. PubMed ID: 10724128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperprolactinemia in mentally ill patients].
    Carvalho MM; Góis C
    Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
    Holt RI
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of hyperprolactinaemia as an entity in psychiatric patients.
    Kohen D; Wildgust HJ
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):6-11. PubMed ID: 18477616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperprolactinaemia and bone mineral density].
    Kostrzak A; Męczekalski B
    Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
    Bushe C; Yeomans D; Floyd T; Smith SM
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):56-62. PubMed ID: 18477621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.